Cargando…
CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis
The mechanistic target of rapamycin (mTOR) and wingless-related integration site (Wnt) signal transduction networks are evolutionarily conserved mammalian growth and cellular development networks. Most cells express many of the proteins in both pathways, and this review will briefly describe only th...
Autores principales: | Evans, Jilly Frances, Obraztsova, Kseniya, Lin, Susan M., Krymskaya, Vera P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956553/ https://www.ncbi.nlm.nih.gov/pubmed/33668092 http://dx.doi.org/10.3390/ijms22052233 |
Ejemplares similares
-
Syndecan-2: Old Player in a New Field
por: Obraztsova, Kseniya, et al.
Publicado: (2019) -
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis
por: Evans, Jilly F., et al.
Publicado: (2023) -
Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells
por: Himes, Blanca E., et al.
Publicado: (2018) -
Inhibition of Growth of TSC2-Null Cells by a PI3K/mTOR Inhibitor but Not by a Selective MNK1/2 Inhibitor
por: Evans, Jilly F., et al.
Publicado: (2019) -
Wild Type Mesenchymal Cells Contribute to the Lung Pathology of Lymphangioleiomyomatosis
por: Clements, Debbie, et al.
Publicado: (2015)